Medable

Medable Inc. is a Palo Alto, California-based software company providing a unified platform for clinical development. The platform bundles electronic clinical outcome assessment (eCOA), eConsent, televisit, connected sensors, provisioned devices and bring-your-own-device support into a single login and view, alongside AI agents that operate across the trial lifecycle. Medable positions the platform for GxP-regulated environments, citing compliance with 21 CFR Part 11, EU Annex 11, HIPAA, GDPR and ICH GCP, and describes audit trails, explainable decision logs and human-in-the-loop oversight as core design elements [0][3].

Product components include Study Studio, a no-code visual study builder with a library of more than 400 validated instruments, an Instrument Generator and a Translation Workbench; agentic modules such as a Clinical Monitoring (CRA) Agent, TMF Agent, PI/Summary Agent and a Digital Data Flow Agent that converts trial protocols into machine-readable data; and a device logistics service covering procurement, provisioning and delivery from six global depots on an all-inclusive monthly rate. An ontology layer plus MCP connectors integrate with existing clinical and enterprise systems including Veeva, Oracle, Medidata, Microsoft 365, Snowflake and BigQuery, with the company citing over 30 validated connectors and connections to 15+ systems [0][3].

Medable frames its objective as a "1:1:1" vision — one-day study start, one-day patient enrollment and one-year study conduct — and markets earlier decentralized clinical trial (DCT) capabilities alongside the newer agentic AI positioning [0][2][3].